Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Psychoneuroendocrinology ; 59: 59-70, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26036451

RESUMEN

Stress or elevated glucocorticoids during sensitive windows of fetal development increase the risk of neuropsychiatric disorders in adult rodents and humans, a phenomenon known as glucocorticoid programming. 11ß-Hydroxysteroid dehydrogenase type 2 (11ß-HSD2), which catalyses rapid inactivation of glucocorticoids in the placenta, controls access of maternal glucocorticoids to the fetal compartment, placing it in a key position to modulate glucocorticoid programming of behavior. However, the importance of the high expression of 11ß-HSD2 within the midgestational fetal brain is unknown. To examine this, a brain-specific knockout of 11ß-HSD2 (HSD2BKO) was generated and compared to wild-type littermates. HSD2BKO have markedly diminished fetal brain 11ß-HSD2, but intact fetal body and placental 11ß-HSD2 and normal fetal and placental growth. Despite normal fetal plasma corticosterone, HSD2BKO exhibit elevated fetal brain corticosterone levels at midgestation. As adults, HSD2BKO show depressive-like behavior and have cognitive impairments. However, unlike complete feto-placental deficiency, HSD2BKO show no anxiety-like behavioral deficits. The clear mechanistic separation of the programmed components of depression and cognition from anxiety implies distinct mechanisms of pathogenesis, affording potential opportunities for stratified interventions.


Asunto(s)
11-beta-Hidroxiesteroide Deshidrogenasa de Tipo 2/metabolismo , Trastornos de Ansiedad/enzimología , Encéfalo/embriología , Encéfalo/enzimología , Trastorno Depresivo/enzimología , Animales , Modelos Animales de Enfermedad , Femenino , Desarrollo Fetal , Glucocorticoides/sangre , Glucocorticoides/metabolismo , Masculino , Intercambio Materno-Fetal/fisiología , Ratones , Ratones Noqueados , Placenta/metabolismo , Embarazo , Factores de Riesgo , Estrés Fisiológico
2.
Eur J Neurosci ; 30(2): 299-306, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19614978

RESUMEN

The 5-HT(2C) receptor has been implicated in mood and eating disorders. In general, it is accepted that 5-HT(2C) receptor agonists increase anxiety behaviours and induce hypophagia. However, pharmacological analysis of the roles of these receptors is hampered by the lack of selective ligands and the complex regulation of receptor isoforms and expression levels. Therefore, the exact role of 5-HT(2C) receptors in mood disorders remain controversial, some suggesting agonists and others suggesting antagonists may be efficacious antidepressants, while there is general agreement that antagonists are beneficial anxiolytics. In order to test the hypothesis that increased 5-HT(2C) receptor expression, and thus increased 5-HT(2C) receptor signalling, is causative in mood disorders, we have undertaken a transgenic approach, directly altering the 5-HT(2C) receptor number in the forebrain and evaluating the consequences on behaviour. Transgenic mice overexpressing 5-HT(2C) receptors under the control of the CaMKIIalpha promoter (C2CR mice) have elevated 5-HT(2C) receptor mRNA levels in cerebral cortex and limbic areas (including the hippocampus and amygdala), but normal levels in the hypothalamus, resulting in > 100% increase in the number of 5-HT(2C) ligand binding sites in the forebrain. The C2CR mice show increased anxiety-like behaviour in the elevated plus-maze, decreased wheel-running behaviour and reduced activity in a novel environment. These behaviours were observed in the C2CR mice without stimulation by exogenous ligands. Our findings support a role for 5-HT(2C) receptor signalling in anxiety disorders. The C2CR mouse model offers a novel and effective approach for studying disorders associated with 5-HT(2C) receptors.


Asunto(s)
Ansiedad/metabolismo , Expresión Génica , Actividad Motora/fisiología , Prosencéfalo/fisiología , Receptor de Serotonina 5-HT2C/biosíntesis , Animales , Ansiedad/genética , Células COS , Chlorocebus aethiops , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Ratones Transgénicos , Ratas , Receptor de Serotonina 5-HT2C/genética
3.
Behav Genet ; 38(3): 292-300, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18347969

RESUMEN

We determined whether altered physical activity levels might underlie the contrasting adiposity of a divergently selected polygenic murine model of metabolic syndrome (Fat; F) and leanness (Lean; L) mice. We measured physical activity with a long term running wheel experiment and performed an additional high fat diet intervention. Further, we measured posture allocation by visual monitoring within the home cage as a non-exercise correlate of 'normal' physical activity. Whilst initially similar, running wheel activity of the F line declined with age, while the activity of the L line increased. Food intake was higher in the L line and increased with wheel exposure. Vertical rearing measured by video quantification in the home cage, without the stimulus of a running wheel was also significantly higher in the L line. The two lines developed novel alternate strategies to defend their body weight when exposed to high fat diets with a running wheel. F mice increased their running wheel activity, and despite unaltered food intake, still gained weight. L mice reduced their food intake and maintained activity levels without a significant change in body weight. Phenotypic selection for divergence in body fat content has co-segregated with a genetic predisposition for divergent physical activity levels and different strategies for coping with exposure to high fat diets that will facilitate the discovery of the genes underlying these important obesity related traits.


Asunto(s)
Actividad Motora , Obesidad/genética , Tejido Adiposo , Alimentación Animal , Animales , Conducta Animal , Peso Corporal , Ingestión de Alimentos , Conducta Alimentaria , Predisposición Genética a la Enfermedad , Escala de Lod , Masculino , Síndrome Metabólico/genética , Ratones , Modelos Genéticos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA